Determination of External Loop Topology in the Serotonin Transporter by Site-directed Chemical Labeling*

The transmembrane topology of the serotonin transporter (SERT) has been examined by measuring the reactivity of selected lysine and cysteine residues with extracellular reagents. An impermeant biotinylating reagent, sulfosuccinimidyl 2-(biotinamido)ethyl-1,3-dithiopropionate (NHS-SS-biotin), was shown to label SERT transiently expressed in cultured cells. Replacement of four lysine residues that were predicted to lie in external hydrophilic loops (eK-less) largely prevented the biotinylation reaction. Likewise, the cysteine-specific biotinylation reagentN-biotinylaminoethylmethanethiosulfonate (MTSEA-biotin) labeled wild type SERT but not a mutant in which Cys-109, predicted to lie in the first external loop, was replaced with alanine. These two mutant transporters reacted with the biotinylating reagents in digitonin-permeabilized cells, demonstrating that the abundant lysine and cysteine residues predicted to lie in intracellular hydrophilic domains were reactive but not accessible in intact cells. Mutants containing a single external lysine at positions 111, 194, 243, 319, 399, 490, and 571 reacted more readily with NHS-SS-biotin than did the eK-less mutant. Similarly, mutants with a single cysteine at positions 109, 310, 406, 489, and 564 reacted more readily with MTSEA-biotin than did the C109A mutant. All of these mutants were active and therefore likely to be folded correctly. These results support the original transmembrane topology and argue against an alternative topology proposed recently for the related glycine and γ-aminobutyric acid transporters.

[1]  M. Kilimann,et al.  A Na(+)-dependent creatine transporter in rabbit brain, muscle, heart, and kidney. cDNA cloning and functional expression. , 1993, The Journal of biological chemistry.

[2]  J. Sneddon Sodium‐dependent accumulation of 5‐hydroxytryptamine by rat blood platelets , 1969, British journal of pharmacology.

[3]  D. Wong,et al.  Dopamine transporter: biochemistry, pharmacology and imaging. , 1990, European neurology.

[4]  G. Rudnick,et al.  An extracellular loop region of the serotonin transporter may be involved in the translocation mechanism. , 1997, Biochemistry.

[5]  O. Lingjaerde Uptake of serotonin in blood platelets: Dependence on sodium and chloride, and inhibition by choline , 1969, FEBS letters.

[6]  R. Blakely,et al.  Molecular cloning and expression of a high affinity l-proline transporter expressed in putative glutamatergic pathways of rat brain , 1992, Neuron.

[7]  G. Vidaver,et al.  Anion effects on glycine entry into pigeon red blood cells. , 1972, Biochimica et biophysica acta.

[8]  S. Amara,et al.  Neurotransmitter transporters: recent progress. , 1993, Annual review of neuroscience.

[9]  S. Brimijoin,et al.  Antipeptide Antibodies Confirm the Topology of the Human Norepinephrine Transporter (*) , 1995, The Journal of Biological Chemistry.

[10]  G. Rudnick,et al.  The Third Transmembrane Domain of the Serotonin Transporter Contains Residues Associated with Substrate and Cocaine Binding* , 1997, The Journal of Biological Chemistry.

[11]  H. Bönisch,et al.  Effects of Monovalent Ions on the Transport of Noradrenaline Across the Plasma Membrane of Neuronal Cells (PC‐12 Cells) , 1985, Journal of neurochemistry.

[12]  R. Blakely,et al.  Inability to N-glycosylate the human norepinephrine transporter reduces protein stability, surface trafficking, and transport activity but not ligand recognition. , 1996, Molecular pharmacology.

[13]  Jing Chen,et al.  External cysteine residues in the serotonin transporter. , 1997, Biochemistry.

[14]  R. Blakely,et al.  The effect of N-linked glycosylation on activity of the Na(+)- and Cl(-)-dependent serotonin transporter expressed using recombinant baculovirus in insect cells. , 1994, The Journal of biological chemistry.

[15]  B. Kanner,et al.  The Membrane Topology of GAT-1, a (Na+ + Cl−)-coupled γ-Aminobutyric Acid Transporter from Rat Brain* , 1997, The Journal of Biological Chemistry.

[16]  C. Giménez,et al.  Analysis of the Transmembrane Topology of the Glycine Transporter GLYT1* , 1997, The Journal of Biological Chemistry.

[17]  C. Giménez,et al.  The Role of N-Glycosylation in the Targeting and Activity of the GLYT1 Glycine Transporter (*) , 1995, The Journal of Biological Chemistry.

[18]  R. Blakely,et al.  Cloning and expression of a functional serotonin transporter from rat brain , 1991, Nature.

[19]  G. Rudnick,et al.  Stable expression of biogenic amine transporters reveals differences in inhibitor sensitivity, kinetics, and ion dependence. , 1994, The Journal of biological chemistry.

[20]  H. Lester,et al.  Cloning and expression of a rat brain GABA transporter. , 1990, Science.

[21]  G. Rudnick,et al.  Biogenic amine flux mediated by cloned transporters stably expressed in cultured cell lines: amphetamine specificity for inhibition and efflux. , 1995, Molecular pharmacology.

[22]  Henry A. Lester,et al.  Listening to Neurotransmitter Transporters , 1996, Neuron.

[23]  M. Kuhar,et al.  Cocaine inhibition of ligand binding at dopamine, norepinephrine and serotonin transporters: a structure-activity study. , 1990, Life sciences.

[24]  G. Yellen,et al.  On the Use of Thiol-modifying Agents to Determine Channel Topology , 1996, Neuropharmacology.

[25]  Randy D. Blakely,et al.  Expression cloning of a cocaine-and antidepressant-sensitive human noradrenaline transporter , 1991, Nature.

[26]  B. Kanner Active transport of gamma-aminobutyric acid by membrane vesicles isolated from rat brain. , 1978, Biochemistry.

[27]  N. Nelson,et al.  Short External Loops as Potential Substrate Binding Site of γ-Aminobutyric Acid Transporters (*) , 1995, The Journal of Biological Chemistry.

[28]  R. Blakely,et al.  Human norepinephrine transporter. Biosynthetic studies using a site-directed polyclonal antibody. , 1994, The Journal of biological chemistry.

[29]  D. Clarke,et al.  Membrane Topology of a Cysteine-less Mutant of Human P-glycoprotein (*) , 1995, The Journal of Biological Chemistry.

[30]  R. Blakely,et al.  Vaccinia-T7 RNA polymerase expression system: evaluation for the expression cloning of plasma membrane transporters. , 1991, Analytical biochemistry.

[31]  F. Marumo,et al.  Molecular cloning of the cDNA for an MDCK cell Na(+)- and Cl(-)-dependent taurine transporter that is regulated by hypertonicity. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[32]  B. Borowsky,et al.  Neurotransmitter transporters: molecular biology, function, and regulation. , 1995, International review of neurobiology.

[33]  E. Richelson Pharmacology of antidepressants--characteristics of the ideal drug. , 1994, Mayo Clinic proceedings.

[34]  G. Uhl,et al.  Neurotransmitter transporters: three important gene families for neuronal function. , 1994, The Journal of experimental biology.

[35]  G. Vidaver,et al.  Transport of glycine by hemolyzed and restored pigeon red blood cells. Symmetry properties, trans effects of sodium ion and glycine, and their description by a single rate equation. , 1968, The Journal of biological chemistry.

[36]  N. Nelson,et al.  Porters and neurotransmitter transporters. , 1994, The Journal of experimental biology.

[37]  R. Robey,et al.  Cloning of a Na(+)- and Cl(-)-dependent betaine transporter that is regulated by hypertonicity. , 1992, The Journal of biological chemistry.

[38]  Janet A. Clark,et al.  Analysis of the Transmembrane Topology and Membrane Assembly of the GAT-1 γ-Aminobutyric Acid Transporter* , 1997, The Journal of Biological Chemistry.